Developing new contraceptive products for non-systemic delivery
BIOLOGICAL TESTING FACILITY (BTF) - DEVELOPMENT OF CONTRACEPTIVE PRODUCTS INTENDED FOR NON-SYSTEMIC DELIVERY
This study is exploring new, safe ways to prevent pregnancy without using traditional methods, so both men and women can have more options for birth control that work effectively and safely.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Sri International NIH-funded |
| Lab location | 1 site (Menlo Park, United States) |
| Project ID | NIH-10936055 on NIH RePORTER |
What this research studies
This research focuses on creating safe and effective contraceptive methods that do not rely on systemic delivery. The Biological Testing Facility (BTF) will evaluate new compounds and formulations through various testing phases, including in vitro and in vivo studies. Patients may benefit from innovative contraceptive options that are tailored to disrupt reproductive processes safely. The research aims to enhance contraceptive choices for both men and women.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research include individuals seeking new contraceptive methods, particularly those interested in non-systemic options.
Not a fit: Patients who are not seeking contraceptive options or those who have contraindications to contraceptive methods may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide patients with new, non-invasive contraceptive options that are safer and more effective.
How similar studies have performed: Previous research in contraceptive development has shown promise, indicating that innovative approaches can lead to successful new methods.
Where this research is happening
Menlo Park, United States
- Sri International — Menlo Park, United States (Active)
Researchers
- Principal investigator: Bunin, Deborah — Sri International
- Study coordinator: Bunin, Deborah
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.